Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proline-rich protein 7, synaptic (PRR7) is a transmembrane adaptor protein predominantly expressed in neurons and activated T cells[1][3][4][6]. In neurons, PRR7 localizes to the postsynaptic density and participates in synaptic modulation, particularly by inducing activity-dependent removal of excitatory synapses via exosomal secretion and inhibition of Wnt signaling[2]. PRR7 also serves as a synapse-to-nucleus signaling messenger, modulating NMDA receptor-mediated gene expression and neuronal survival in a c-Jun-dependent manner; its activity links synaptic activity to apoptosis, contributing to excitotoxic neuronal death relevant to neurodegenerative diseases[3][4][6]. In the immune system, PRR7 modulates T cell receptor signaling and apoptosis, fine-tuning immune activation and survival responses[3]. Despite its clear roles in neuronal and T-cell biology, there are currently no known marketed drugs or targeted therapeutics acting directly on PRR7, nor well-characterized use as a disease biomarker or safety concern beyond those related to apoptosis and neurotoxicity[2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proline-rich protein 7, synaptic (PRR7).